Location: Home > Pharma China Web Edition
  • search
  • go
  • People in the News
    China BioPharma Appoints Mr. Shenqian Nie, the CEO of CITIC Pharmaceutical to the Independent Board of Directors 5/16/2006
    ISELIN, N.J.--(BUSINESS WIRE)--May 10, 2006--Techedge, Inc. (OTCBB: TEDG) announced that China BioPharma, Ltd. appointed Shenqian Nie, to the company's Board of Directors.

    Peter Wang commented, "China BioPharma is pleased to announce the appointment of Mr. Shenqian Nie as a new independent member of the Board of Directors. As the current CEO of CITIC Pharmaceutical's, Mr. Nie is an experienced leader within China's pharmaceutical sector, and will prove to be a great asset in expanding China BioPharma, Ltd. business within in China and abroad".

    Mr. Nie current serves as the CEO of CITIC Pharmaceuticals, which generated around $300 million in revenue last year. Mr. Nie also holds the position of Chairman for Hainan CITIC Biopharmaceutical Development Company, which is the major Influenza vaccine distributor within China. Hainan CITIC Biopharmaceutical Development was responsible for the distribution of $6 million in Influenza vaccines in China last year for Chiron Vaccines. Before entering the commercial sector, Mr. Nie held a position as an official with China's CDC (Center for Disease Control).

    Relate News
  • Site map | Contact Us | Links
  • © Wicon International Group